Trademark Overview
On Tuesday, December 31, 2024, a trademark application was filed for IC with the United States Patent and Trademark Office. The USPTO has given the IC trademark a serial number of 98931154. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Saturday, June 14, 2025. This trademark is owned by NANOIMMUNOCEL Inc. The IC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Antibodies for medical purposes; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer immunotherapy; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer
Pharmaceutical research and development; Providing information about medical and scientific research via a website; Providing medical and scientific research information; Providing medical research and scientific research information in the field of oncology via the Internet; Consulting services in the field of pharmaceutical research and development; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer